Skip to Main Content

Paper Details

Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma.
Cancers (Basel)
10
2019
CDK, CYC065, Cyclin-Dependent Kinase, GBM, GBM cells, GBM neurospheres, Glioblastoma, Mcl-, PDX, PDX models, Patient, TRAIL, cyclin-dependent kinase, human, human GBM neurospheres, human death receptor 5, patient, patient-, patient-derived, primary brain tumor, seliciclib, tumor necrosis factor-related apoptosis-inducing ligand
Author NameAffiliation
Keith L LigonDana-Farber Cancer Institute
Annette T ByrneRoyal College of Surgeons in Ireland
  • 1 - 2

Datasets

Release 1.2